Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.

Exclusion Criteria

• •Subject has been diagnosed with schizophrenia less than 6 months prior to Screening Visit.
• •Subject has received within 90 days of Screening Visit: electroconvulsive therapy; transcranial magnetic stimulation; vagal nerve stimulation; or other brain stimulation treatments
• •Subject has experienced acute depressive symptoms within 30 days prior to Screening Visit that requires treatment with an antidepressant, as determined by the Investigator.
• •Currently taking clozapine for the treatment of schizophrenia.
• •Has hypothyroidism or hyperthyroidism.
• •Subject is currently being treated with insulin for diabetes.
• •Subject has epilepsy or history of seizures.
• •Positive urine pregnancy test.